Table 3.
Comparison of blood anti-PLA2R fluorescence intensity between stages II and III and stages I, IV, and V.
| Group | ± to + | ++ to +++ | Total |
|---|---|---|---|
| Stages I, IV, and V | 42 | 0 | 42 |
| Stages II and III | 3 | 34 | 37 |
| Total | 45 | 34 | 79 |
x 2=68.76, p < 0.001.
Comparison of blood anti-PLA2R fluorescence intensity between stages II and III and stages I, IV, and V.
| Group | ± to + | ++ to +++ | Total |
|---|---|---|---|
| Stages I, IV, and V | 42 | 0 | 42 |
| Stages II and III | 3 | 34 | 37 |
| Total | 45 | 34 | 79 |
x 2=68.76, p < 0.001.